Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.
- DOI
- 10.1016/s2213-8587(18)30036-6
- Published
- 2018 May
- Container
- The lancet. Diabetes & endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2213-8587-18-30036-6,
title = {Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.},
author = {Sivaprasad S and Vasconcelos JC and Prevost AT and Holmes H and Hykin P and George S and Murphy C and Kelly J and Arden GB and CLEOPATRA Study Group},
year = {2018},
journal = {The lancet. Diabetes \& endocrinology},
doi = {10.1016/s2213-8587(18)30036-6},
url = {https://doi.org/10.1016/s2213-8587(18)30036-6}
}RIS
TY - JOUR TI - Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial. AU - Sivaprasad S AU - Vasconcelos JC AU - Prevost AT AU - Holmes H AU - Hykin P AU - George S AU - Murphy C AU - Kelly J AU - Arden GB AU - CLEOPATRA Study Group PY - 2018 JO - The lancet. Diabetes & endocrinology DO - 10.1016/s2213-8587(18)30036-6 UR - https://doi.org/10.1016/s2213-8587(18)30036-6 ER -
APA
S, S., JC, V., AT, P., H, H., P, H., S, G., C, M., J, K., GB, A., & Group, C. S. (2018). Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.. The lancet. Diabetes & endocrinology. https://doi.org/10.1016/s2213-8587(18)30036-6
Source records
- pubmed · retrieved 2026-09-26T23:59:01.387Z
- europe-pmc · retrieved 2026-09-26T23:59:01.405Z